UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition HermolepsinR-100mg-PRTablet-SE-AJ-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100000265-00010790, http://ema.europa.eu/fhir/eurdId
/539
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Prolonged-release tablet
indication:
Epilepsier: Generaliserade anfall av grand mal-typ (toniskt-kloniska). Partiella anfall. Karbamazepin är ej verksamt vid absenser (petit mal). Trigeminusneuralgi. Alkoholabstinens.
legalStatusOfSupply: Medicinal product subject to medical prescription
classification: carbamazepine
name
productName: Hermolepsin Retard 100 mg Depottablett
part
part: Hermolepsin Retard
type: Invented Name Part
part
part: 100 mg
type: Strength part
part
part: Depottablett
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish